{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-272890","form_type":"8-K","ticker":"CGEM","cik":"0001789972","company_name":"Cullinan Therapeutics, Inc.","filed_at":"2026-06-16T21:18:15+00:00","discovered_at":"2026-06-16T21:20:00.374049+00:00","generated_at":"2026-06-16T21:20:31.677382+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Cullinan Therapeutics reports annual meeting results; all proposals approved","bullets":["Shareholders elected Nadim Ahmed and Stephen Webster as Class III directors for three-year terms.","Ratified KPMG LLP as independent auditor for fiscal year 2026 with 53.7M votes for, 36.8K against.","Advisory vote on executive compensation approved with 48.5M for, 1.1M against."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-272890","json":"https://secwatch.observer/filing/0001193125-26-272890.json","markdown":"https://secwatch.observer/filing/0001193125-26-272890.md","text":"https://secwatch.observer/filing/0001193125-26-272890.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1789972/000119312526272890/0001193125-26-272890-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1789972/000119312526272890/cgem-20260616.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T21:20:31.677382+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6e86ad75a8f76ecb7056db7d02523390e052272b","claim":"Cullinan Therapeutics, Inc. shareholders approved Ratification of Appointment of KPMG LLP as Independent Registered Public Accounting Firm at the 2026-06-16 meeting.","evidence_excerpt":"The Company's stockholders ratified the appointment of KPMG LLP as the Company's independent registered accounting firm for the fiscal year ending December 31, 2026 by the following votes: Votes For Votes Against Abstentions Broker Non-Votes 53,722,477 36,815 3,138 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1789972/000119312526272890/0001193125-26-272890-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-16"}],"fact_type":"shareholder_vote"},{"claim_id":"8c586ac4892cb586755604a1a8136f664b815ef9","claim":"Cullinan Therapeutics, Inc. shareholders approved Election of Class III Directors at the 2026-06-16 meeting.","evidence_excerpt":"The Company's stockholders elected two Class III directors to the Company's Board of Directors for three-year terms or until his successor has been duly elected and qualified, or until his earlier death, resignation or removal, by the following votes: Nominee Votes For Votes Withheld Broker Non-Votes Nadim Ahmed 37,519,241 12,116,759 4,126,430 Stephen Webster 36,963,086 12,672,914 4,126,430","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1789972/000119312526272890/0001193125-26-272890-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-16"}],"fact_type":"shareholder_vote"},{"claim_id":"dd74f7002fbf1ab785e2919ff87d6249cc8e60e3","claim":"Cullinan Therapeutics, Inc. shareholders approved Advisory Vote on Executive Compensation at the 2026-06-16 meeting.","evidence_excerpt":"The Company's stockholders approved the advisory vote on the compensation of the Company's named executive officers by the following votes: Votes For Votes Against Abstentions Broker Non-Votes 48,536,734 1,092,209 7,057 4,126,430","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1789972/000119312526272890/0001193125-26-272890-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-16"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}